Introduction
Evaluation of couples with Recurrent Pregnancy Loss
Married pair who has recurrent pregnancy loss really needs empathy as well as the consideration that early pregnancy loss is an extremely psychologically upsetting incident that is one way or another comparable to that associated with stillbirth or neonatal death. For the information, evaluation can be provoking and complex because the root of their recurrent pregnancy loss may not be obtained and there are only some evidence-based investigative and related solution techniques.
The evaluation used for the clients who are the potential to have recurrent pregnancy loss is characteristically identified as the incidence of more than two successive fatalities of medically renowned pregnancies before the 20th week of gestation excluding ectopic and molar pregnancies. Wide-ranging accord in presented that hale and hearty women must not undergo wide evaluation after the first trimester or before the time of second trimester, Unprompted miscarriage, given these are relatively common, sporadic events: miscarriage occurs in about 10 to 15 percent of clinically recognized pregnancies under 20 weeks of gestation.
In forthcoming studies, the whole risk of miscarriage that lies in the next pregnancy remains almost or more than 15 percent after having the first miscarriage but it rises to about 17 to 31 percent after having the two successive miscarriages and to 25 to 46 percent after more than two miscarriages. Based on these findings gathered from the statistics, almost all the experts do the task in evaluation and management related to recurrent pregnancy loss.
It is vital to put in mind that most women with recurrent pregnancy loss have a good projection for eventually having a successful pregnancy, even when there is a definitive diagnosis that is not completed and no dealing commenced. The couple with frequent pregnancy losses is subject to have a series of history and physical examinations including complete medical, surgical and genetic.
During the history taking, gestational age and characteristics of all preceding pregnancies should be considered for the reason that gestational age is vital because recurrent pregnancy losses usually take place at a similar gestational age in following pregnancies and the main general reason for the reoccurrence of pregnancy losses varies by trimester. For example, miscarriage associated with chromosomal and endocrine defects is likely to happen earlier in gestation than losses due to anatomic or immunological irregularity but it goes beyond. Pregnancy loss such as ectopic pregnancy, abortion happened during the 5th and 20th week of gestation.
In physical examination, there must be an overall physical appraisal that gives notice to signs of endocrinopathy, examples of it are hirsutism and galactorrhea, and pelvic organ abnormalities that include uterine deformity and cervical laceration. There are plenty of questions related to pregnancy losses that are significant in investigating miscarriage: Has there been uterine instrumentation that may be a cause for intrauterine adhesions? Are the menstrual cycles of the potential patient for miscarriage normal? In relation to the question, endocrine dysfunction may affect the menstrual cycle span.
Other queries: Is there galactorrhea that also suggests endocrine dysfunction such as hyperprolactinemia? Is there a history of inborn abnormalities or karyotypic aberrations that can be inherited? Was fetal cardiac movement spotted? There are several things that may suggest chromosomal anomalies; one of them is the recurrent pregnancy losses before the detection of embryonic cardiac activity. Is there evidence that the family history displays outlines of disease reliable with a strong genetic influence? Is consanguinity exists? Is there a contact to ecological contaminants, which may be fatal to developing embryos? Is there a history of venous thrombosis that suggests an innate thrombophilia or antiphospholipid syndrome? Is there any information existing from the previous laboratory, pathology, and imaging studies that is related to miscarriage? The discussion will provide further data on the subject of investigations on recurrent miscarriages.
Discussion
Most useful tests
There are various tests that will enable the physician and the client to detect any troublesome regarding pregnancy that will enable them to classify the nature of miscarriage and to at least lessen the possibility of it. The most useful tests are as follows: One is Karyotype, even if it has only limited predictive value and low yield of aberration. It perceives unbiased reciprocal or Robertsonian translocations, there is a possibility that the fetus will get uneven.
If the earlier tests conducted gave a negative result, this is the only time that karyotyping is conducted. An analysis of cytogenetic results in 79 available surveys of couples with two or more pregnancy losses (n = 8208 women and 7834 men) observed the large incidence of chief chromosome abnormalities was 2.9 percent that is more than five of the universal adult populace. As a result, a lot of specialists karyotype recommend that the cause of miscarriage is a maternal environmental factor. On the other hand, an atypical karyotype, which is aneuploidy, is an adequate explanation for a nonviable pregnancy. The second is the Uterine assessment.
Anatomic reasons for the occurrence of recurrent miscarriage are usually diagnosed using hysterosalpingography (HSG) or sonohysterography. The second one is more in more convenient to use because of its accuracy as compared to HSG and it provides more data than sonography alone. The third is Hysteroscopy, it is the most advisable for a finding of intrauterine abnormalities. Because of its price and invasiveness, a hysteroscopic uterine appraisal is kept for patients who have had a non-diagnostic evaluation of recurrent miscarriage.
Fourth is Ultrasound, it gives an idea regarding the existence as well as the location of uterine myomas and, the likelihood of cervical incompetency and appraisal of fetal viability in pregnancy. Fifth is Magnetic resonance imaging, it helps in differentiating a septate from a bicornuate uterus suspected on ultrasonography or HSG. The least amount of immunology workup for women with recurrent miscarriage is a measurement of anticardiolipin antibody (IgG and IgM) and lupus anticoagulant. The two are indicated to be done twice and six to eight weeks apart, because a low to mid positive level can be the reason for viral illness and regress to normal.
The anticardiolipin antibody titer is classified as elevated if medium or high titers of both IgG and IgM isotypes are there in blood. An activated partial thromboplastin time, kaolin plasma clotting time, or dilute Russell viper venom test time is the basis to detect the lupus anticoagulant. Hypercoagulable status is another test wherein there is a big and contradictory text with regards to maternally inherited thrombophilia and persistent spontaneous abortion that occurs in the first trimester. A thyroid function test must be done in women with symptoms of thyroid disease because most studies report an increased threat of miscarriage in women with subclinical hypothyroidism. In one case, five women experienced subclinical and medical hypothyroidism after a miscarriage concluding the loss itself may have prompted hypothyroidism.
Numerous reviews have reported an enlarged rate of fetal loss in women with high serum thyroid peroxidase antibody (TPO) levels. This was best shown by a randomized trial that reported the miscarriage pace in TPO-positive women was much higher compared to those with no antibody. Moreover, this trial illustrated that thyroid replacement was advantageous in minimizing the number of miscarriages to that observed in TPO-negative women. The authors proposed that euthyroid TPO-positive pregnant women have weakened thyroid function that can lead to miscarriage, early delivery as well as clinical hypothyroidism all through pregnancy.
Other studies have suggested better pregnancy results with carefully monitored thyroid hormone management. Evaluation of ovarian reserve with the use of a day 3 follicle-stimulating hormone (FSH) concentration can serve as an evaluation of recurrent pregnancy loss in women of various ages. In one study review, FSH or E levels even were augmented in 58 percent of women who have an unexplained recurrent miscarriage and in 19 percent of controls with an identified cause for their recurrent pregnancy loss and Medical work-up is supplementary laboratory tests may be indicated in women with symptoms that suggest medical disorder. Yet, testing for these disorders must not be a fraction of the usual evaluation of women with intermittent miscarriage.
Less useful tests
There are also less useful tests related to investigations of recurrent miscarriages, Culture and serology are one example, regular cervical cultures for Chlamydia sp. or Mycoplasma sp., vaginal evaluation for bacterial vaginosis, and toxoplasmosis serology otherwise to healthy women. The pregnancy result of women with and without antinuclear antibody (ANA) is similar and recent information does not bear testing women with recurrent miscarriage.
Screening for diabetes be supposed to limit to women with clinical manifestations of the disease, only those poorly controlled diabetes is linked with miscarriage. The immune function test requires advanced investigation and validation. Progesterone level determination, single or multiple sera, is not prognostic of future pregnancy products. Diagnosis of a luteal phase deficiency had been based upon the outcome of endometrial biopsy. Though, high-quality information demonstrates that this test is not predictive of fertility condition; hence, it is no longer suggested.
Conclusion
Management: Summary and Recommendation
In the case of recurrent miscarriage, it is recommended for the women to undergo evaluation after two or three consecutive miscarriages to avoid recurrence of it and to be able for the support group to help the couple in coping. The evaluation should be accomplished step by step so that every pertinent detail regarding miscarriage will be scrutinized. Obtaining Gestational age is important because the occurrence of miscarriage usually occurs at the same gestational age, by trimester, so in this manner, women are being informed about what to do and what to avoid during the incidence of pregnancy loss. Same with the Physical examination, it should contain a general physical appraisal that will help the physician and client to detect whether there are threats for miscarriage.
The following tests are recommended for the initial evaluation of women with recurrent miscarriage: Sonohysterography for appraisal of uterine abnormalities, Anticardiolipin antibody (IgG and IgM) titer and lupus anticoagulant analysis that is conducted twice and six to eight weeks apart, Thyroid-stimulating hormone (TSH) specifically, the Day 3 FSH and estradiol concentrations to obtain ovarian reserve, Factor V Leiden mutation, stimulates protein C resistance, protein S deficiency, and prothrombin mutation screening if fetal losses happened after nine weeks of gestation, Parental karyotype together with karyotype of the abortus if the above tests are normal and further testing will be implemented based upon the diagnosis demands by the history and physical examination that were held during the assessment phase.
Reference
- Trott, EA, Russell, JB, Plouffe, L Jr (1996). A review of the genetics of recurrent pregnancy loss.
- Plouffe, L Jr, White, EW, Tho, SP, (1992). Etiologic factors of recurrent abortion and subsequent reproductive performance of couples: have we made any progress in the past 10 years?
- Stirrat, (1990). Recurrent miscarriage.
- American College of Obstetricians and Gynecologists, (2001). Management of recurrent early pregnancy loss. Washington, DC.
- Anderson, DG, Stenzel, C, (2001). Internet patient care applications in ambulatory care. J Ambulatory Care Manage.
- Laufer, MR, Ecker, JL, Hill, JA, (1994). Pregnancy outcome following ultrasound-detected fetal cardiac activity in women with a history of multiple spontaneous abortions. J Soc Gynecol Investigating.
- Negro, R, Formoso, G, Mangieri, T, (2006). Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications.
- Clark, DA, Daya, S, Coulam, CB, Gunby, J, (1996). The implication of abnormal human trophoblast karyotype for the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion.
- Carp, H, Guetta, E, Dorf, H, (2006). Embryonic karyotype in recurrent miscarriage with parental karyotypic aberrations.
- Tharapel, AT, Tharapel, SA, Bannerman, RM, (1985). Recurrent pregnancy losses and parental chromosome abnormalities: a review.
- Schaeffer, AJ, Chung, J, Heretis, K, (2004). Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages.
- Goldberg, JM, Falcone, T, Attaran, M, (1997). Sonohysterographic evaluation of uterine abnormalities noted on hysterosalpingography.
- Soares, SR, Barbosa dos Reis MMB, Camargos AF, (2000). Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases.
- Homer, HA, Li, TC, Cooke, I, (2000). The septate uterus: a review of management and reproductive outcome.
- Malhotra, N, Sood, M, (1997). Role of hysteroscopy in infertile women.
- Ansari, AH, Kirkpatrick, B, (1998). Recurrent pregnancy loss. An update.
- Roubey, (2000). Update on Antiphospholipid antibodies.
- Stephenson, (1996). Frequency of factors associated with habitual abortion in 197 couples.
- Vinatier, D, Dufour, P, Cosson, M, Houpeau, JL, (2001). Antiphospholipid syndrome and recurrent miscarriages.
- Ohara, N, Tsujino, T, Maruo, T, (2004). The role of thyroid hormone in trophoblast function, early pregnancy maintenance, and fetal neurodevelopment.
- Shah, MS, Davies, TF, Stagnaro-Green, A, (2003). The thyroid during pregnancy: a physiological and pathological stress test.
- Poppe, K, Glinoer, D, (2003). Thyroid autoimmunity and hypothyroidism before and during pregnancy.
- Abalovich, M, Gutierrez, S, Alcaraz, G, (2007). Overt and subclinical hypothyroidism complicating pregnancy.
- Glinoer, D, Riahi, M, Grun, JP, Kinthaert, J, (1994). Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders.
- Christiansen, OB, Nybo Andersen, AM, Bosch, E, (2005). Evidence-based investigations and treatments of recurrent pregnancy loss.
- Marqusee, E, Hill, JA, Mandel, SJ (1997). Thyroiditis after pregnancy loss.
- Negro, R, Mangieri, T, Coppola, L, (2005). Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study.
- Vaquero, E, Lazzarin, N, De Carolis, C, (2000). Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach.
- Trout, SW, Seifer, DB, (2000). Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values?
- Coulam, (1992). Immunologic tests in the evaluation of reproductive disorders: a critical review.
- Ogasawara, M, Kajiura, S, Kantano, K, (1997). Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies?
- Peters, AJ, Lloyd, RP, Coulam, CB, (1992). Prevalence of out-of-phase endometrial biopsy specimens.